|Articles|May 1, 2004
Phakic IOLs offer good outcomes to high myopes and hyperopes
The U.S. FDA study of the Implantable Collamer Lens (ICL, STAAR Surgical)used to treat high myopia (mean preoperative refraction, -10 D) and availablein four lengths (11.5 to 13 mm) shows good visual results in 526 eyes. Thesedata were presented at the American Society of Cataract and Refractive Surgery(ASCRS) annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases
2
8 things to know about aflibercept 8 mg for retinal vascular disease
3
How AI is reshaping ophthalmology in 2025 and beyond
4
Reimagining dry eye care: Focus on sustained tear production
5



































